Insights

Immunotherapy Advancements Cullinan Therapeutics focuses on developing immunotherapy solutions targeting autoimmune diseases, presenting a sales opportunity for partnerships with healthcare providers specializing in autoimmune disorder treatments.

Financial Growth Potential With reported revenues ranging from $10M to $50M, Cullinan Therapeutics showcases potential for business collaborations aimed at expanding its portfolio, creating avenues for sales growth.

Investment by Assenagon GmbH Assenagon Asset Management S.A.'s significant investment in Cullinan Therapeutics demonstrates investor confidence, indicating a potential sales opportunity for financial services tailored towards biotech firms.

Leadership Enhancement The recent appointment of Mary Kay Fenton as the Chief Financial Officer signifies Cullinan Therapeutics' commitment to strengthening its leadership team, creating opportunities for sales partnerships with financial management firms.

Participation in Industry Events Cullinan Therapeutics actively engages in industry conferences signaling openness to collaborations and partnerships within the biotechnology sector, presenting opportunities for networking and sales discussions.

Cullinan Therapeutics Tech Stack

Cullinan Therapeutics uses 8 technology products and services including Atlassian, Drupal, Webpack, and more. Explore Cullinan Therapeutics's tech stack below.

  • Atlassian
    Application Development & Management
  • Drupal
    Content Management System
  • Webpack
    Development
  • ADP HRMS
    Human Resource Management System
  • Microsoft
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Tailwind CSS
    UI Frameworks
  • Atlassian Confluence
    Wikis

Media & News

Cullinan Therapeutics's Email Address Formats

Cullinan Therapeutics uses at least 2 format(s):
Cullinan Therapeutics Email FormatsExamplePercentage
FLast@cullinanoncology.comJDoe@cullinanoncology.com
92%
Last@cullinanoncology.comDoe@cullinanoncology.com
4%
First@cullinanoncology.comJohn@cullinanoncology.com
1%
FMiddleLast@cullinanoncology.comJMichaelDoe@cullinanoncology.com
1%
FirstLast@cullinanoncology.comJohnDoe@cullinanoncology.com
1%
F.Last@cullinanoncology.comJ.Doe@cullinanoncology.com
1%

Frequently Asked Questions

Where is Cullinan Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cullinan Therapeutics's main headquarters is located at 1 Main St Cambridge, Massachusetts 02142 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Cullinan Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Cullinan Therapeutics is a publicly traded company; the company's stock symbol is CGEM.

What is Cullinan Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cullinan Therapeutics's official website is cullinantherapeutics.com and has social profiles on LinkedIn.

How much revenue does Cullinan Therapeutics generate?

Minus sign iconPlus sign icon
As of April 2025, Cullinan Therapeutics's annual revenue reached $35M.

What is Cullinan Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cullinan Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cullinan Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2025, Cullinan Therapeutics has approximately 122 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: J. J.Chief Technical Operations Officer: K. J.Chief Scientific Officer: J. M.. Explore Cullinan Therapeutics's employee directory with LeadIQ.

What industry does Cullinan Therapeutics belong to?

Minus sign iconPlus sign icon
Cullinan Therapeutics operates in the Biotechnology Research industry.

What technology does Cullinan Therapeutics use?

Minus sign iconPlus sign icon
Cullinan Therapeutics's tech stack includes AtlassianDrupalWebpackADP HRMSMicrosoftYoast SEOTailwind CSSAtlassian Confluence.

What is Cullinan Therapeutics's email format?

Minus sign iconPlus sign icon
Cullinan Therapeutics's email format typically follows the pattern of . Find more Cullinan Therapeutics email formats with LeadIQ.
Cullinan Therapeutics

Cullinan Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Cullinan Therapeutics is dedicated to creating new standards of care for patients. 
 
We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.  

Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.

Notice to Job Seekers: Job applicants should be aware of job recruitment, interview and offer scams being perpetrated through the use of the internet and social media platforms. To learn more, visit our Careers page or read Cullinan’s Employment Recruitment Scams Notice here: https://cullinantherapeutics.com/docs/employment-recruitment-scams-notice.pdf

Section iconCompany Overview

Headquarters
1 Main St Cambridge, Massachusetts 02142 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CGEM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $10M$50M

    Cullinan Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Cullinan Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.